Anavex Life Sciences Corp (AVXL)

[kld2]

Poppycock! In any developmental biotech they have a drug in the pipeline whose success will be determined, ultimately, in a Phase 2 or Phase 3 trial; until then, until they do a randomized, double-blind, placebo-controlled trial, with hundreds of patients, they have little or no idea how successful the drug will be (99.6% of all ALZ have failed). He moved to NASDAQ to have more access to capital, giving him more time to roll the clinical die. Period.